Literature DB >> 19464922

Sustained improvement after combined anterior mitral valve leaflet retention plasty and septal myectomy in preventing systolic anterior motion in hypertrophic obstructive cardiomyopathy in children.

Eva Maria B Delmo Walter1, Henryk Siniawski, Roland Hetzer.   

Abstract

OBJECTIVE: Anatomic alterations of the mitral valve such as increased mitral leaflet area, length and laxity, and anterior displacement of the papillary muscles in hypertrophic obstructive cardiomyopathy predispose patients to residual systolic anterior motion and persistence of outflow obstruction and mitral regurgitation after septal myectomy. We investigate the long-term results of combined anterior mitral leaflet retention plasty and septal myectomy in children with hypertrophic obstructive cardiomyopathy. METHODS AND
RESULTS: Anterior mitral leaflet retention plasty and subaortic septal myectomy were performed in 12 children (mean age 10.8+/-1.7 years) with hypertrophic obstructive cardiomyopathy. Mean preoperative left ventricular outflow tract pressure gradient was 49+/-11 mmHg. After careful assessment of the mobility of the anterior leaflet and subvalvular apparatus, segments of the anterior leaflet nearest the trigones were sutured to the corresponding posterior annulus with polypropylene reinforced with untreated autologous pericardial pledgets. Intraoperative valve orifice measurement based on age-related valve diameter ensures that no mitral stenosis is produced. Mean intraoperative pre- and post-septal myectomy pressure gradient was 60+/-25 mmHg and 5+/-6 mmHg, respectively. Post-myectomy mitral insufficiency was reduced to a regurgitant fraction of 0-10%. Mean follow-up is 11.85+/-1.22 years. Mean left ventricular outflow tract pressure gradient was 6.2+/-3.95 mmHg. No mortality, no repeat myectomy or repeat mitral valve repair or replacement, no mitral stenosis and no systolic anterior motion occurred.
CONCLUSIONS: Long-term follow-up shows sustained absence of systolic anterior motion, attenuation of mitral regurgitation, sustained improvement in functional status, and reduction of outflow tract obstruction.

Entities:  

Mesh:

Year:  2009        PMID: 19464922     DOI: 10.1016/j.ejcts.2009.03.049

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  7 in total

1.  Mitral valve replacement and trans-mitral myectomy for a child with Noonan syndrome accompanied by hypertrophic obstructive cardiomyopathy.

Authors:  Takashi Sasaki; Toshihide Asou; Makoto Shirakawa; Ken-Ichiro Takahashi; Shinobu Kunugi; Takashi Nitta
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-02-19

Review 2.  Management of the mitral valve in patients with obstructive hypertrophic cardiomyopathy.

Authors:  Joon Hwa Hong; Anita Nguyen; Hartzell Vernon Schaff
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-05-07

3.  Long-term outcome of simultaneous septal myectomy and anterior mitral leaflet retention plasty in hypertrophic obstructive cardiomyopathy: the Berlin experience.

Authors:  Eva Maria Delmo Walter; Mariano Francisco Javier; Roland Hetzer
Journal:  Ann Cardiothorac Surg       Date:  2017-07

4.  Safety and efficacy of alcohol septal ablation in adolescents and young adults with hypertrophic obstructive cardiomyopathy.

Authors:  Dennis Lawin; Thorsten Lawrenz; Kristin Radke; Christoph Stellbrink
Journal:  Clin Res Cardiol       Date:  2021-11-24       Impact factor: 5.460

Review 5.  Systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: a narrative review.

Authors:  Sarah A Guigui; Christian Torres; Esteban Escolar; Christos G Mihos
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

6.  Keynote Lecture-Transmitral hypertrophic obstructive cardiomyopathy (HOCM) repair.

Authors:  Friedrich W Mohr; Joerg Seeburger; Martin Misfeld
Journal:  Ann Cardiothorac Surg       Date:  2013-11

7.  Concomitant septal myectomy and mitral valve repair in a child with Noonan syndrome.

Authors:  Toshio Doi; Daisuke Toritsuka; Akihiko Higashida; Shigeki Yokoyama; Kazuaki Fukahara; Naoki Yoshimura
Journal:  Clin Case Rep       Date:  2020-11-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.